@article{TGH5629,
author = {Darren D. Browning},
title = {The enduring promise of phosphodiesterase 5 inhibitors for colon cancer prevention},
journal = {Translational Gastroenterology and Hepatology},
volume = {4},
number = {0},
year = {2019},
keywords = {},
abstract = {Cancers of the colon and rectum (CRC) are some of the most commonly diagnosed and are responsible for 9% of all cancer deaths due to the late stage of diagnosis where treatments are largely ineffective. Prevention of CRC is therefore very important for high-risk patients. The average lifetime risk of developing CRC varies widely between countries, but once diagnosed, the risk increases 3–5 folds for first-person relatives and for recurrence in the patient (1).},
issn = {2415-1289}, url = {https://tgh.amegroups.org/article/view/5629}
}